1. Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells
   Christina M Ward et al, 2016, Exp Biol Med (Maywood) CrossRef
2. Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer
   Yeqing Huang et al, 2017 CrossRef
3. Integrative genomic analyses of the RNA-binding protein, RNPC1, and its potential role in cancer prediction
   Zhiming Ding et al, 2015, Int J Mol Med CrossRef
4. MicroRNAs in the Pathogenesis of Renal Cell Carcinoma and Their Diagnostic and Prognostic Utility as Cancer Biomarkers
   Michal Fedorko et al, 2016, The International Journal of Biological Markers CrossRef
5. Epigenetics in renal cell cancer: mechanisms and clinical applications.
   Sophie C Joosten et al, 2018, Nat Rev Urol CrossRef
6. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
   Eman A Toraih et al, 2018, PLoS One CrossRef
7. MiR-34a regulates the glucose metabolism of Blunt snout bream (Megalobrama amblycephala) fed high-carbohydrate diets through the mediation of the Sirt1/FoxO1 axis
   Ling-Hong Miao et al, 2018, Aquaculture CrossRef
8. Expression of YY1 in Wilms tumors with favorable histology is a risk factor for adverse outcomes
   Marta Zapata-Tarres et al, 2019, Future Oncology CrossRef
9. YY1 Regulates Cancer Cell Immune Resistance by Modulating PD-L1 Expression
   Emily Hays et al, 2019, Drug Resistance Updates CrossRef
10. A network-biology perspective of microRNA function and dysfunction in cancer.
    Cameron P Bracken et al, 2016, Nat Rev Genet CrossRef
11. Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity
    Jin-Yong Lee et al, 2016, Sci Rep CrossRef
12. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: A therapeutic target
    Benjamin Bonavida et al, 2015, Pharmacology & Therapeutics CrossRef
13. Methylation of miRNA genes and oncogenesis
    V. I. Loginov et al, 2015, Biochemistry Moscow CrossRef
14. YY1 regulates melanoma tumorigenesis through a miR-9 ~ RYBP axis
    Guowei Zhao et al, 2015, J Exp Clin Cancer Res CrossRef
15. Epigenetic regulators: Polycomb-miRNA circuits in cancer
    Filomena de Nigris, 2016, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
16. Inverse correlation between the metastasis suppressor RKIP and the metastasis inducer YY1: Contrasting roles in the regulation of chemo/immuno-resistance in cancer.
    Stephanie Wottrich et al, 2017, Drug Resist Updat CrossRef
17. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα
    Leifeng Chen et al, 2020, Oncogene CrossRef
18. null
    Mario Morales-Martinez et al, 2021 CrossRef
19. null
    Silvia Vivarelli et al, 2021 CrossRef
20. MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
    Mehdi Sajjadi-Dokht et al, 2021, Genes & Diseases CrossRef